Encephalitis Vaccination Market

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito s classes. People and many animals may be infection source after infection Encephalitis virus.
Encephalitis Vaccination Market contains market size and forecasts of Encephalitis Vaccination in global, including the following market information:

• Global Encephalitis Vaccination Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Encephalitis Vaccination Market Sales, 2017-2022, 2023-2028, (10K Person-time)
• Global top five Encephalitis Vaccination companies in 2021 (%)

The global Encephalitis Vaccination market was valued at 1328.6 million in 2021 and is projected to reach US$ 1914.7 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Encephalitis B Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Encephalitis Vaccination include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Encephalitis Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Encephalitis Vaccination Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (10K Person-time)
Global Encephalitis Vaccination Market Segment Percentages, by Type, 2021 (%)

• Encephalitis B Vaccine
• Encephalitis Attenuated Live Vaccine

Global Encephalitis Vaccination Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (10K Person-time)
Global Encephalitis Vaccination Market Segment Percentages, by Application, 2021 (%)

• Public Hospital
• Private Hospital
• Clinic
• Other

Global Encephalitis Vaccination Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (10K Person-time)
Global Encephalitis Vaccination Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Encephalitis Vaccination revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Encephalitis Vaccination revenues share in global market, 2021 (%)
• Key companies Encephalitis Vaccination sales in global market, 2017-2022 (Estimated), (10K Person-time)
• Key companies Encephalitis Vaccination sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Sanofi
• Chengdu Institute of Biological Products
• Wuhan Institute of Biological Products
• Lanzhou Institute of Biological Products
• Beijing Taitan
• Valneva
• Bharat Biotech
• Liaoning Chengda

To know more about market statistics, Download a FREE Sample copy